208 related articles for article (PubMed ID: 33760187)
1. Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells.
Freund E; Miebach L; Stope MB; Bekeschus S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760187
[TBL] [Abstract][Full Text] [Related]
2. Entacapone is an Antioxidant More Potent than Vitamin C and Vitamin E for Scavenging of Hypochlorous Acid and Peroxynitrite, and the Inhibition of Oxidative Stress-Induced Cell Death.
Chen AY; Lü JM; Yao Q; Chen C
Med Sci Monit; 2016 Mar; 22():687-96. PubMed ID: 26927838
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.
van Stein RM; Aalbers AGJ; Sonke GS; van Driel WJ
JAMA Oncol; 2021 Aug; 7(8):1231-1238. PubMed ID: 33956063
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
5. A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin.
Miailhe G; Arfi A; Mirshahi M; Eveno C; Pocard M; Touboul C
J Visc Surg; 2018 Jun; 155(3):183-189. PubMed ID: 29108718
[TBL] [Abstract][Full Text] [Related]
6. Simulating drug penetration during hyperthermic intraperitoneal chemotherapy.
Löke DR; Helderman RFCPA; Franken NAP; Oei AL; Tanis PJ; Crezee J; Kok HP
Drug Deliv; 2021 Dec; 28(1):145-161. PubMed ID: 33427507
[TBL] [Abstract][Full Text] [Related]
7. Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells.
Lloyd MM; Grima MA; Rayner BS; Hadfield KA; Davies MJ; Hawkins CL
Free Radic Biol Med; 2013 Dec; 65():1352-1362. PubMed ID: 24120969
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies.
Cascales Campos PA; González-Gil A; Gómez-Ruiz AJ; Gil-Gómez E; Alconchel-Gago F; Navarro-Barrios A; Martínez-García J; Alonso-Romero JL; Nieto A; Barceló-Valcarcel F; Gil-Martínez J
Hernia; 2020 Apr; 24(2):257-263. PubMed ID: 31069579
[TBL] [Abstract][Full Text] [Related]
9. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer.
Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F
Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658
[TBL] [Abstract][Full Text] [Related]
10. Impact of Perfusate Concentration on Hyperthermic Intraperitoneal Chemotherapy Efficacy and Toxicity in a Rodent Model.
Liesenfeld LF; Hillebrecht HC; Klose J; Schmidt T; Schneider M
J Surg Res; 2020 Sep; 253():262-271. PubMed ID: 32388389
[TBL] [Abstract][Full Text] [Related]
11. Potential role of methionine sulfoxide in the inactivation of the chaperone GroEL by hypochlorous acid (HOCl) and peroxynitrite (ONOO-).
Khor HK; Fisher MT; Schöneich C
J Biol Chem; 2004 May; 279(19):19486-93. PubMed ID: 14757771
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels.
Zhang M; Bao Y; Zhang H; Li D; Mei X; Cheng X
J Obstet Gynaecol; 2023 Dec; 43(1):2204940. PubMed ID: 37186893
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: Our Initial Experience.
Bartoş A; Bartoş D; Raluca S; Mitre C; Hadade A; Iancu I; Cioltean C; Iancu C; Militaru C; Părău A; Breazu C
Chirurgia (Bucur); 2019; 114(2):222-233. PubMed ID: 31060655
[No Abstract] [Full Text] [Related]
14. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O;
Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of sulfonyl acrylonitriles as novel inhibitors to peritoneal carcinomatosis.
Zificsak CA; Shen Y; Lisko JG; Theroff JP; Lao X; Bollt O; Li X; Dorsey BD; Kuwada SK
Bioorg Med Chem Lett; 2012 Mar; 22(5):1850-3. PubMed ID: 22326395
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia.
Pelz JO; Vetterlein M; Grimmig T; Kerscher AG; Moll E; Lazariotou M; Matthes N; Faber M; Germer CT; Waaga-Gasser AM; Gasser M
Ann Surg Oncol; 2013 Apr; 20(4):1105-13. PubMed ID: 23456378
[TBL] [Abstract][Full Text] [Related]
17. Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI).
Steffen T; Häller L; Bijelic L; Glatzer M; Glehen O; Goéré D; de Hingh I; Li Y; Moran BJ; Morris DL; Piso P; Quadros CA; Rau B; Sugarbaker P; Yonemura Y; Putora PM
Oncology; 2021; 99(1):41-48. PubMed ID: 32920557
[TBL] [Abstract][Full Text] [Related]
18. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
19. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
[TBL] [Abstract][Full Text] [Related]
20. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
